These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 2761875

  • 1. The response to treatment with pituitary growth hormone: the New Zealand experience.
    Livesey JH, Cuneo RC, Donald RA, Harris RG, Ibberston HK, Costello JM, Holdaway IM, Gluckman PD, Fraser TR, Chapman GE.
    N Z Med J; 1989 Aug 09; 102(873):399-402. PubMed ID: 2761875
    [Abstract] [Full Text] [Related]

  • 2. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D, Garel C, Limoni C, Czernichow P, Léger J.
    Clin Endocrinol (Oxf); 2003 May 09; 58(5):647-52. PubMed ID: 12699449
    [Abstract] [Full Text] [Related]

  • 3. Growth response in prepubertal children with idiopathic growth hormone deficiency during the first two years of treatment with human growth hormone. Analysis of the Kabi Pharmacia International Growth Study.
    Ranke MB, Guilbaud O.
    Acta Paediatr Scand Suppl; 1991 May 09; 379():109-15; discussion 116. PubMed ID: 1815451
    [Abstract] [Full Text] [Related]

  • 4. Growth and growth hormone therapy in children with achondroplasia: a two-year experience.
    Stamoyannou L, Karachaliou F, Neou P, Papataxiarchou K, Pistevos G, Bartsocas CS.
    Am J Med Genet; 1997 Oct 03; 72(1):71-6. PubMed ID: 9295079
    [Abstract] [Full Text] [Related]

  • 5. Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classic growth hormone deficiency.
    Zadik Z, Chalew S, Zung A, Landau H, Leiberman E, Koren R, Voet H, Hochberg Z, Kowarski AA.
    J Pediatr; 1994 Aug 03; 125(2):189-95. PubMed ID: 8040760
    [Abstract] [Full Text] [Related]

  • 6. [The effectiveness of recombinant growth hormone in height deficiency due to intrauterine growth retardation].
    Vicens-Calvet E, Seijo G, Potau N, de los Llanos Moreno M, Carrascosa A.
    Med Clin (Barc); 1999 May 08; 112(16):601-5. PubMed ID: 10374174
    [Abstract] [Full Text] [Related]

  • 7. Predictors of growth response to rhGH in short children before and after renal transplantation. German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
    Wühl E, Haffner D, Tönshoff B, Mehls O.
    Kidney Int Suppl; 1993 Oct 08; 43():S76-82. PubMed ID: 8246375
    [Abstract] [Full Text] [Related]

  • 8. [Treatment with recombinant human growth hormone (rhGH) in children with chronic kidney failure or renal transplantation].
    Crosnier H, Guest G, Souberbielle JC, Broyer M, Rappaport R.
    Arch Pediatr; 1994 Aug 08; 1(8):716-22. PubMed ID: 7842104
    [Abstract] [Full Text] [Related]

  • 9. Combined test of hypothalamic-pituitary function in growth retarded children treated with growth hormone. I. Secretion of growth hormone and somatomedin before and after treatment.
    Kastrup KW, Andersen H, Eskildsen PC, Jacobsen BB, Krabbe S, Petersen KE.
    Acta Paediatr Scand Suppl; 1979 Aug 08; 277():8-13. PubMed ID: 396757
    [Abstract] [Full Text] [Related]

  • 10. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency.
    Cavallo L, Gurrado R, Zecchino C, Manolo F, De Sanctis V, Cisternino M, Caruso-Nicoletti M, Galati M.
    J Pediatr Endocrinol Metab; 1998 Aug 08; 11 Suppl 3():845-9. PubMed ID: 10091155
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of hypophyseal dwarfism with biosynthetic growth hormone].
    Blümel P, Stögmann W.
    Wien Klin Wochenschr; 1989 Dec 22; 101(24):861-3. PubMed ID: 2623878
    [Abstract] [Full Text] [Related]

  • 12. Growth hormone improves weight velocity and height velocity in prepubertal children with cystic fibrosis.
    Hardin DS, Stratton R, Kramer JC, Reyes de la Rocha S, Govaerts K, Wilson DP.
    Horm Metab Res; 1998 Oct 22; 30(10):636-41. PubMed ID: 9851673
    [Abstract] [Full Text] [Related]

  • 13. Medical Research Council of Canada therapeutic trial of human growth hormone: first 5 years of therapy.
    Guyda H, Friesen H, Bailey JD, Leboeuf G, Beck JC.
    Can Med Assoc J; 1975 Jun 07; 112(11):1301-9. PubMed ID: 165002
    [Abstract] [Full Text] [Related]

  • 14. [Clinical and biochemical evaluation of the administration of growth hormone].
    Mendoza-Morfin F, Cárdenas-Tirado H.
    Bol Med Hosp Infant Mex; 1990 Aug 07; 47(8):551-6. PubMed ID: 2257092
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of somatotropic deficiency with biosynthetic growth hormone].
    Spagnoli A, Bernardini S, Galasso C, Vaccaro F, Manca Bitti ML, Scirè G, Cianfarani S, Spadoni GL.
    Pediatr Med Chir; 1989 Aug 07; 11(4):413-8. PubMed ID: 2694106
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone treatment in short children with chronic renal failure and after renal transplantation: combined data from European clinical trials. The European Study Group.
    Van Es A.
    Acta Paediatr Scand Suppl; 1991 Aug 07; 379():42-8; discussion 49. PubMed ID: 1815459
    [Abstract] [Full Text] [Related]

  • 17. Growth hormone treatment for short stature.
    Van Vliet G, Styne DM, Kaplan SL, Grumbach MM.
    N Engl J Med; 1983 Oct 27; 309(17):1016-22. PubMed ID: 6684729
    [Abstract] [Full Text] [Related]

  • 18. A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. French Serono Study Group.
    Rappaport R, Mugnier E, Limoni C, Crosnier H, Czernichow P, Leger J, Limal JM, Rochiccioli P, Soskin S.
    J Clin Endocrinol Metab; 1997 Feb 27; 82(2):452-6. PubMed ID: 9024235
    [Abstract] [Full Text] [Related]

  • 19. Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome--a clinical research center study. GHIS Collaborative Group.
    Backeljauw PF, Underwood LE.
    J Clin Endocrinol Metab; 1996 Sep 27; 81(9):3312-7. PubMed ID: 8784089
    [Abstract] [Full Text] [Related]

  • 20. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study.
    Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price DA.
    J Clin Endocrinol Metab; 1999 Apr 27; 84(4):1174-83. PubMed ID: 10199749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.